Email: cspc@cspc.cn

Contact Us
EN

News

News

Home > Media > News > VOLUNTARY ANNOUNCEMENT OLAPARIB TABLETS OBTAINS DRUG REGISTRATION APPROVAL

VOLUNTARY ANNOUNCEMENT OLAPARIB TABLETS OBTAINS DRUG REGISTRATION APPROVAL

June 03, 2024

VOLUNTARY ANNOUNCEMENTOLAPARIB TABLETS OBTAINS DRUG REGISTRATION APPROVAL_00.png

VOLUNTARY ANNOUNCEMENT OLAPARIB TABLETS OBTAINS DRUG REGISTRATION APPROVAL

Previous: CSPC Baike Awarded "Yantai Green Factory"

Next: VOLUNTARY ANNOUNCEMENT RECOMBINANT FULLY HUMAN ANTI-βKlotho MONOCLONAL ANTIBODY DRUG (JMT202) OBTAINS CLINICAL TRIAL APPROVAL

Contact Us

Phone:

+86 311 8703 7015

Email:

cspc@cspc.cn

Products

Science

About Us

Legal terms Privacy protection
Copyright © CSPC Pharmaceutical Group Co., Ltd. All Rights Reserved |

Wechat